With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Linking mitogenic sonic hedgehog signaling to the oncogene Yap 1 in neural stem/progenitor cells and medulloblastoma.||Memorial Sloan-Kettering Cancer Center / Anna Kenney, PhD||Innovation Grants||2009||New York|
|Modeling anaplastic medulloblastoma using cerebellar stem cells||Duke University / Robert Wechsler-Reya, PhD||Innovation Grants||2009||North Carolina|
|Investigating the role of lin-28 in germ cell tumorigenesis||Boston Children’s Hospital / George Daley||Innovation Grants||2009||Massachusetts|
|BH3 profiling to define therapy resistance classes in neuroblastoma.||Children’s Hospital of Philadelphia / Michael Hogarty||Innovation Grants||2009||Pennsylvania|
|Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.||Huntsman Cancer Institute / Stephen Lessnick||Innovation Grants||2009||Utah|
|Metabolic control of p53 activation in T-ALL.||Duke University / Jeffrey Rathmell||Innovation Grants||2009||North Carolina|
|Biology-based clinical trials for children with cancer.||Children’s Hospital of Philadelphia / Rochelle Bagatell||Phase I/II Infrastructure Grants||2009||Pennsylvania|
|Development of a childhood leukemia translational research program.||Dana-Farber Cancer Institute / Lewis Silverman||Phase I/II Infrastructure Grants||2009||Massachusetts|
|Pediatric Oncology Translational Research Program||Vanderbilt University Medical Center / James Whitlock, M.D.||Phase I/II Infrastructure Grants||2009||Tennessee|
|Expanding access to new agents for children with refractory cancers: the experimental therapeutics program at Children's Hospital of Colorado.||Children’s Hospital Colorado / Lia Gore, MD||Phase I/II Infrastructure Grants||2009||Colorado|